The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
@Magzy No reply from the company as of yet. Disappointing from an investors perspective. Although I hope I will receive a reply today.
I would like to top up, but will need confirmation of their finances from the company themselves. I would be upset if a placing does occur, as they could have given us holders the option to participate in this, however I do not think it will impact the SP much, especially with the fundamentals to hand.
Good luck and please keep me updated if you get a response yourself.
Read on ADFVN that potential placing is coming? Can anyone confirm whether the company are fully funded for the covid test + track and trace? Surely £250,000 warrants is not enough.
Can anyone confirm their financial position, currently reading through their RNS's and on their website, but only saw that they have just over £1m as of 26th June 2020. Does anyone know how long this has lasted them and if they have spent this already? Considering the issue of warrants only 4 months (from June 2020) after they announced £1m in cash.
I've emailed the company today and hopefully will get a reply soon.
I bought in yesterday at 3.59p, wanted to add more today but would rather wait if they are doing a placing soon!
Good luck all, any response on their finances will be helpful, I'll update the board once I receive a response from the company themselves.
New Job Description for Genedrive – “As we further develop our Point of Care solutions through assay development and product refinement, we have an OPPORTUNITY TO REACH MILLIONS OF PEOPLE who currently have limited access to existing diagnostic technology. As we RAMP UP our focus on delivering affordable point of care in vitro molecular diagnostics for addressing global infectious disease challenges, we are looking to strengthen our Quality Team with the addition of a Quality Assurance Technician. Closing Date: For internal applicants Wednesday 21st October 2020”.
‘Ramp up’ and ‘millions’ seems positive… David an update before Wednesday next week would be grand. Looking good here, David making progress as per our previous commercial products. Hope everyone has managed to digest things over the weekend.
Genedrive recruiting staff = expansion towards commercialisation. Great posts @CharlieSam (recommended!).
Taken from your post…“In the summer, when Omega Diagnostic were recruiting to expand their Covid testing (exactly what we’re seeing here with Genedrive), Omega Diagnostic’s LSE board was filled with them. Many Omega holders sold their shares and later bought them back at a higher price, due to nonsense being spouted across accounts. You’re seeing the exact same tactics here. It was later found out by Omega Holders that these Fear Mongers got in at their lower price point and laughed about it in their private chat rooms.
Remember, Genedrive’s recruitment news means expansion. If you’re worried about your investment here, DYOR and then sell if you’re not satisfied. However, know what you’re holding first, or you’ll regret your decision. Especially as there’s 10 working days left this month.”
Looking forward to see what happens next week.
Hope you're all well!
According to chartists, a close above 0.43 would be bullish. Bring on next week!
Good luck all.
Can see us going into tier 3 by the end of this month as individuals will break the rules of Tier 2, therefore seeing a spike in Covid cases by next week.
I believe BGF are completely out and we'll get the holdings RNS on Monday, hence why we've been stuck at this price, despite the huge buying pressure. Over 100,000 shares have been bought today between friends and family members, but only a few have popped up.
Lets get those 500 units with the DoD confirmed to bring us back to 170p, and bring on the testing news!
Good luck all!
Premier Miton Group adding to their position and a large investor took a position.
Big buys not showing on LSE today, MMs picking up shares too! This is primed for a big move very soon.
Can't wait to get to see 1.02 again and then hopefully 3 to 5p for long term holders to breakeven.
Good luck all!
Hi Magsy18,
That's why I'm suprised we're not at 300p, not shying away from anything. If it wasn't for BGF I believe this would have occurred. Standing by my convictions that we will see over 300p soon, but only time will tell.
Just read your comment on owning 300,000 shares, hope that's true. Want to see everyone become prosperous and gain the potentials from the company.
When SP rerates, you'll too be happy then. Everyone do their research and you'll understand how undervalued we are.
Good luck all!
A one in a life time opportunity this could be for investors. I’m surprised at the current low share price, thought we’d be at least 300p by now.
Take all this in carefully and do your research to understand the current potential.
Long term holders that know we were once Epistem Holdings know how ridiculously cheap we currently are.
We have connections with experienced and successful companies (i.e. billion-dollar companies) in India, Africa and the US where our current products are supplied. All our past product applications have been previously granted in various jurisdictions. Therefore, I have no doubt this will be the same for the Covid19 lab test.
News soon/this month:
1. Africa Distribution sales.
2. US FDA approval and then immediate contracts with Beckman (will be in the multiple of millions).
3. India approval, which according to sources have already been granted (just waiting for the RNS).
4. The other portable Covid19 test which will be valuable worldwide and even in the UK. This test could possibly be used in care homes, schools and even at transport checkpoints. You can’t dismiss any UK contracts for this, especially with what’s currently happening with Greater Manchester and the North of England.
5. Units contract with DoD.
This company is seriously at a huge growth stage and will be a multimillion-pound company this year.
The share price has the potential to easily get back to 580p and even above, especially with all this news flow. It’s not a matter of IF, but WHEN.
With Covid19 increasing worldwide and new lockdown measures in place, the whole of the UK is likely to be back into lockdown, make sure you inform your friends and family to research into Genedrive/Epistem Holdings if they are looking for a good company to help the world against this virus. This is my gift to you.
Good luck to us investors who can see the potential of this Gem of a company. Stay safe, we’re heading into FLU SEASON!
Topped up more at this ridiculous price. MMs putting it as a sell on the books.
All I can say is we won't be at this level for much longer.
Good luck too you all!
Over the past months, I’ve seen some comments stating that 300p is not likely, those are clearly from new investors who have invested only this year. These investors probably did not know Genedrive were once called EpiStem, whom first listed at 124p a share (SP just above 90p now). However, like most diagnostic, pharma, medical and biotech companies, there is a huge decrease in SP over the years, until they meet their milestones.
Genedrive was trading over 500p in 2014 and 300p less than 5 years ago. I’ve been in Genedrive for some time now, added in mid-April 2020, May 2020 and this week. I’ve seen the ups and downs of the SP, and seen many impatient investors/traders panicking and selling.
For the new investors who seem to be excited (yet anxious) about only the covid tests, consider the following points:
1. Genedrive has more than one product.
2. Covid statistics show that it is not going away. The supply for testing worldwide is less than the demand. All companies producing covid tests with great partners will benefit, Genedrive is in this category.
3. Genedrive are working with the US Department of Defence and already have FDA approved products. I’m confident their first covid test will receive approvals in all countries, especially FDA approval (already achieved CE marking, which at the time investors were doubting). The covid test is produced by Cytiva, whom have operations in the US, and also have produced many FDA approved products in the past.
4. FDA approval is likely to drop anytime between now and in two weeks.
5. The Beckman deal shows huge potential.
6. Genedrive at a £50m market cap is tiny, this could easily be over £150m market cap (300p stock), compare them to their UK peers.
DYOR. Good luck to all.
https://www.theguardian.com/film/2020/aug/26/tom-cruise-performs-death-defying-stunt-watching-tenet-in-a-packed-cinema
Initial signs look good given, all eyes on the opening weekend box now - we only need a 40% turnout compared to similar openings to hit the target $5M in the UK! Ready for a recovery!!